Cargando…

First person – Katherine Robinson

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Katherine Robinson is first author on ‘ Flow cytometry allows rapid detection of protein ag...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524659/
http://dx.doi.org/10.1242/dmm.049289
_version_ 1784585522793938944
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Katherine Robinson is first author on ‘ Flow cytometry allows rapid detection of protein aggregates in cellular and zebrafish models of spinocerebellar ataxia 3’, published in DMM. Katherine is a PhD student in the lab of Dr Angela Laird at Macquarie University, Sydney, Australia, using pre-clinical animal models (transgenic zebrafish and mice) to find new therapeutics for the treatment of neurodegenerative diseases.
format Online
Article
Text
id pubmed-8524659
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-85246592021-10-19 First person – Katherine Robinson Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Katherine Robinson is first author on ‘ Flow cytometry allows rapid detection of protein aggregates in cellular and zebrafish models of spinocerebellar ataxia 3’, published in DMM. Katherine is a PhD student in the lab of Dr Angela Laird at Macquarie University, Sydney, Australia, using pre-clinical animal models (transgenic zebrafish and mice) to find new therapeutics for the treatment of neurodegenerative diseases. The Company of Biologists Ltd 2021-10-11 /pmc/articles/PMC8524659/ http://dx.doi.org/10.1242/dmm.049289 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Katherine Robinson
title First person – Katherine Robinson
title_full First person – Katherine Robinson
title_fullStr First person – Katherine Robinson
title_full_unstemmed First person – Katherine Robinson
title_short First person – Katherine Robinson
title_sort first person – katherine robinson
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524659/
http://dx.doi.org/10.1242/dmm.049289